LarryILipshultzMD

Professor, Urology, Baylor College of Medicine

Dr. Lipshultz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
7200 Cambridge St
Houston, TX 77030
Phone+1 713-798-4001

Fax+1 713-798-6007

Dr. Lipshultz is Professor of Urology and Chief of the Scott Department of Urology’s Division of Male Reproductive Medicine and Surgery at Baylor College of Medicine in Houston, Texas. Dr. Lipshultz, who holds the Smith Chair in Reproductive Medicine, is a well-known authority on abnormalities of male reproduction, erectile dysfunction, and male hormone therapy. He has published more than 400 journal articles and has instituted a fellowship training program in male reproductive medicine and surgery that has trained more than 120 physicians who are now in practice both here and abroad.

University of Pennsylvania Health SystemResidency, Urology, 1973 - 1975
University of Pennsylvania Health SystemResidency, Urology, 1969 - 1971
Presbyterian Medical Center of the University of Pennsylvania Health SystemInternship, Transitional Year, 1968 - 1969
Perelman School of Medicine at the University of PennsylvaniaClass of 1968

America's Top Doctors Castle Connolly, 2002-2014
Top Doctors:SE Texas Castle Connolly, 2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FACS) American College of Surgeons
Join now to see all

H-22411: BOTOX® for Peyronie's Disease Start of enrollment: 2009 Aug 07
Completed
Phase 2
Testosterone for Penile Rehabilitation After Radical Prostatectomy Start of enrollment: 2007 Nov 01
Terminated
Early Phase 1
Androxal in Male Infertility Start of enrollment: 2014 Sep 22
Withdrawn
Phase 2, Phase 3
The Effects of Natesto For Treatment Of Hypogonadism Start of enrollment: 2024 Mar 01
Withdrawn
Early Phase 1
Roles: Principal Investigator, Contact
Join now to see all

PubMed

Legends of Urology (#AUA23) W/ Dr. Larry Lipshultz | BackTable Urology Podcast Ep. 95April 29th, 2023
Inherent Biosciences Raises a Series a to Elevate Standard of Care in Male Reproductive HealthSeptember 6th, 2022
What Your Teeth May Reveal About Your PenisJanuary 22nd, 2021
Join now to see all